CSM’s Employee Spotlight Featuring: Paul McMillen

Congratulations Paul McMillen for 14 years of service with Cornerstone Senior Marketing!

As 2024 marks Paul’s impressive 36th year in the Health/Medicare insurance industry, his perseverance has been the cornerstone of his successful career. He has dedicated extensive time to staying informed about industry trends and developments, committed to assisting our agents in business growth and education.

Cornerstone Senior Marketing wants to thank Paul for his amazing service to our agents and to our team!

CMS CY2025 MA & Part D Final Rule

Background

On April 4, 2024, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that revises the Medicare Advantage Program, Medicare Prescription Drug Benefit Program (Medicare Part D), Medicare Cost Plan Program, Programs of All-Inclusive Care for the Elderly (PACE), and Health Information Technology Standards and Implementation Specifications. Additionally, this final rule addresses several key provisions that remain from the CY 2024 Medicare Advantage and Part D proposed rule, CMS-4201-P, published on December 14, 2022. Together, the changes in this final rule build on existing Biden-Harris Administration policies to strengthen protections and guardrails, promote healthy competition, and ensure Medicare Advantage and Part D plans best meet the needs of enrollees. In addition, these policies promote access to behavioral health care providers, promote equity in coverage, and improve supplemental benefits.

This fact sheet discusses the major provisions of the 2025 final rule which can be downloaded here: https://www.federalregister.gov/public-inspection/2024-07105/medicare-program-medicare-advantage-and-the-medicare-prescription-drug-benefit-program-for-contract

 

CMS Newsroom Medicare Part D

Final CY 2025 Part D Redesign Program Instructions Fact Sheet

| Medicare Part DToday, the Centers for Medicare & Medicaid Services (CMS) released the Final Calendar Year (CY) 2025 Part D Redesign Program Instructions (the Final Program Instructions) concurrently with the CY 2025 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies (the Rate Announcement). The purpose of the Final Program Instructions is to provide interested parties with guidance for CY 2025 regarding, among other topics, the implementation of section 11201 of the Inflation Reduction Act of 2022 (IRA) (P.L. 117-169), signed into law on August 16, 2022, which made several amendments and additions to the Social Security Act (“the Act”) that affect the structure of the defined standard Part D drug benefit.

READ FULL RELEASE